89bio Inc (ETNB)
9.28
+0.19
(+2.09%)
USD |
NASDAQ |
May 15, 15:33
89bio Stock Buybacks (Quarterly): -21.07M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -21.07M |
December 31, 2023 | -162.66M |
September 30, 2023 | 0.512M |
June 30, 2023 | -24.18M |
March 31, 2023 | -310.24M |
December 31, 2022 | -20.39M |
September 30, 2022 | -68.39M |
June 30, 2022 | -28.19M |
March 31, 2022 | -0.029M |
December 31, 2021 | -3.776M |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | 0.607M |
September 30, 2020 | -158.29M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -87.69M |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.011M |
March 31, 2019 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-310.24M
Minimum
Mar 2023
0.607M
Maximum
Dec 2020
-51.99M
Average
-20.39M
Median
Dec 2022
Stock Buybacks (Quarterly) Benchmarks
Akero Therapeutics Inc | -355.44M |
Madrigal Pharmaceuticals Inc | -311.56M |
Viking Therapeutics Inc | -597.12M |
Galectin Therapeutics Inc | -- |
Terns Pharmaceuticals Inc | -13.69M |